Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Shares Out (Diluted) Over TimeStable
Percentile Rank29
3Y CAGR-4.1%
5Y CAGR-2.6%
Studio
Year-over-Year Change

Weighted average diluted shares outstanding

3Y CAGR
-4.1%/yr
vs -0.5%/yr prior
5Y CAGR
-2.6%/yr
Consistent
Acceleration
-3.6pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
4 yr
Consecutive declineStable
PeriodValueYoY Change
2025123904000.00-4.3%
2024129424000.00-3.6%
2023134197000.00-4.6%
2022140608000.00-4.2%
2021146796000.00+3.8%
2020141463000.00-2.0%
2019144329000.00+0.5%
2018143599000.00+3.3%
2017139068000.00+8.7%
2016127964000.00-